Publications by authors named "A M Yassine"
Lebanon, plagued by political and economic crises, experienced a government collapse in early 2020, leading to an electrical nationwide blackout by 2023. Diesel generators were used to compensate for the absence of power production from the national provider, Electricité du Liban (EDL). To investigate the effect of the crisis on the levels of 16 EPA particle bound polycyclic aromatic hydrocarbons (PPAHs), an annual comparative analysis of three locations within Beirut started in 2022 and ended in 2023.
View Article and Find Full Text PDFArticle Synopsis
- This study investigated the prevalence and associated risk factors of nosocomial infections (NIs) in a pediatric intensive care unit from July 2021 to May 2022.
- Out of 396 analyzed patients, 102 experienced NIs, leading to an overall incidence rate of 44.7%, with specific infections primarily caused by gram-negative bacteria.
- Key risk factors included longer hospitalization periods and the use of invasive medical devices, along with antibiotic treatment.
Objective: This systematic review aimed to analyze animal and human trial data to better understand the efficacy of stem cell therapy (SCT) for erectile dysfunction (ED) and the obstacles that may hinder its application in this field.
Methods: We searched electronic databases, including PubMed and Scopus, for published studies with the Medical Subject Heading terms of "erectile dysfunction" (AND) "stem cell therapy" (OR) "erectile dysfunction" (AND) "clinical trial of stem cell therapy" (OR) "stem cell therapy" (AND) "sexual dysfunction". The search was limited to English-language journals and full papers only.
Article Synopsis
- Ethylene oxide (EtO) is a volatile organic compound and carcinogen, with limited reliable data on its ambient concentrations near production facilities, raising exposure concerns.
- In February 2023, sensitive mobile measurements in southeastern Louisiana showed that 75% of sampled areas had EtO levels above the threshold associated with a 1-in-a-million cancer risk, with some locations exceeding levels indicating a 1-in-1,000 risk.
- This study revealed higher EtO concentrations than previous EPA estimates and highlights the need for improved monitoring methods to assess exposure risks in industrial areas.
Background Nonselective beta-blockers (NSBBs) have been used in the management of portal hypertension and the prevention of initial and recurrent variceal bleeding in patients with liver cirrhosis. However, there is controversy regarding the use of NSBBs in patients with decompensated cirrhosis (DC) due to concerns over potential adverse effects, such as worsening of hepatic function and risk of hepatorenal syndrome (HRS). HRS is a serious complication of DC characterized by acute kidney injury (AKI) and progressive renal failure, and its development can lead to significant morbidity and mortality in this setting.
View Article and Find Full Text PDF